Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cadre Holdings, Inc.CDRE · Entity 4819 | Director | May 30, 2025 | June 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cadre Holdings, Inc.
Report date May 30, 2025 · Filed June 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $32.77 · Expires 2035-05-30 | Direct | 16,000 |
Reported balance
After 2025-05-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-05-30 · Grant · Acquired 16,000 · Balance 16,000 F1: The option to purchase shares of Cadre Holdings, Inc. (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's 2021 Stock Incentive Plan. Options to purchase 4,000 shares of the Issuer's Common Stock will vest and become exercisable in four equal consecutive quarterly tranches on each of June 30, 2025, September 30, 2025, December 31, 2025, and March 31, 2026, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: The option to purchase shares of Cadre Holdings, Inc. (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's 2021 Stock Incentive Plan. Options to purchase 4,000 shares of the Issuer's Common Stock will vest and become exercisable in four equal consecutive quarterly tranches on each of June 30, 2025, September 30, 2025, December 31, 2025, and March 31, 2026, respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2025 Filed Jun 3, 2025 20:48 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantStock Option (right to purchase) · Derivative | 16,000 | $0.00 Strike: $32.77 | $0.00 |
DisclosureSEC source: 0001104659-25-056004 · tm2516916-3_4seq1.xml · derivative · entry 1 Delzanno Gianmaria C · CIK 0001297590 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2035-05-30 F1 · derivative.exercise_date: The option to purchase shares of Cadre Holdings, Inc. (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's 2021 Stock Incentive Plan. Options to purchase 4,000 shares of the Issuer's Common Stock will vest and become exercisable in four equal consecutive quarterly tranches on each of June 30, 2025, September 30, 2025, December 31, 2025, and March 31, 2026, respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.